Renewing Lamzede (Velmanase Alfa-tycv) Approval with Aetna in Texas: Complete 2024 Guide to Reauthorization, Documentation, and Appeals
Answer Box: Renewing Lamzede with Aetna in Texas
Lamzede (velmanase alfa-tycv) requires annual reauthorization with Aetna. Start the renewal process 60 days before your current authorization expires. You'll need updated clinical documentation showing continued benefit: improved or stable 6-minute walk test, pulmonary function (FVC), or reduced serum oligosaccharides.